The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Open accessAbstract
Serotonergic hallucinogens produce profound changes in perception, mood, and cognition. These drugs include phenylalkylamines such as mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM), and indoleamines such as (+)-lysergic acid diethylamide (LSD) and psilocybin. Despite their differences in chemical structure, the two classes of hallucinogens produce remarkably similar subjective effects in humans, and induce cross-tolerance. The phenylalkylamine hallucinogens are selective 5-HT2 receptor agonists, whereas the indoleamines are relatively non-selective for serotonin (5-HT) receptors. There is extensive evidence, from both animal and human studies, that the characteristic effects of hallucinogens are mediated by interactions with the 5-HT2A receptor. Nevertheless, there is also evidence that interactions with other receptor sites contribute to the psychopharmacological and behavioral effects of the indoleamine hallucinogens. This article reviews the evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT2 and non-5-HT2 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–276 of 276
Glennon, R. A., Titeler, M., & Young, R. (1986) · PubMed · Cited by 57
An hallucinogenic amphetamine analog (DOM) in man
Hollister, L. E., Macnicol, M. F., & Gillespie, H. K. (1969) · Psychopharmacology · doi:10.1007/bf00401535 · Cited by 56
Leysen, J. E. (2003) · Humana Press eBooks · doi:10.1385/0-89603-122-5:299 · Cited by 56
Mittman, S. M., & Geyer, M. A. (1991) · Psychopharmacology · doi:10.1007/bf02316866 · Cited by 55
Self-citationIsmaiel, A. M., Angeles, J. D. L., Teitler, M., Ingher, S. P., & Glennon, R. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a010 · Cited by 55
Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys
Li, J., Rice, K. C., & France, C. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130625 · Cited by 52
Quérée, P., Peters, S., & Sharp, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00406.x · Cited by 51
Role of serotonin in the discriminative stimulus properties of mescaline
Browne, R. G., & Ho, B. T. (1975) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(75)90052-0 · Cited by 51
LEHMANNMASTEN, V., & Geyer, M. A. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90083-n · Cited by 50
Self-citationHeekeren, K., Neukirch, A., Daumann, J., Stoll, M., Obradovic, M., Kovar, K. ‐., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077734 · Cited by 50
Self-citationMarona‐Lewicka, D., Chemel, B. R., & Nichols, D. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1238-0 · Cited by 49
Smith, R. L., Barrett, R. J., & Sanders‐Bush, E. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1252-6 · Cited by 49
Quednow, B. B., Geyer, M. A., & Halberstadt, A. L. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70102-8 · Cited by 49
Self-citationHalberstadt, A. L., Buell, M. R., Masten, V. L., Risbrough, V. B., & Geyer, M. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1247-z · Cited by 48
Self-citationSogawa, C. A., Sogawa, N., Tagawa, J., Fujino, A., Ohyama, K., Asanuma, M., Funada, M., & Kitayama, S. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.02.007 · Cited by 47
Darmani, N. A., Martin, B. R., Pandey, U., & Glennon, R. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90047-l · Cited by 47
Fiorella, D. J., Helsley, S., Rabin, R. A., et al. (1995) · Psychopharmacology · doi:10.1007/bf02246545 · Cited by 47
Gresch, P. J., Barrett, R. J., Sanders‐Bush, E., & Smith, R. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112946 · Cited by 46
Newton, R. A., PHIPPS, S. L., Flanigan, T. P., Newberry, N. R., Carey, J. E., Kumar, C. S., McDonald, B., Chen, C., & Elliott, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062521.x · Cited by 46
Trulson, M. E., Heym, J. H., & Jacobs, B. L. (1981) · Brain Research · doi:10.1016/0006-8993(81)90507-2 · Cited by 45
Blood Flow and Cerebral Laterality in the Mescaline Model of Psychosis
Hermle, L., Gouzoulis-Mayfrank, E., & Spitzer, M. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979352 · Cited by 44
Dissociations Between the Effects of LSD on Behavior and Raphe Unit Activity in Freely Moving Cats
Trulson, M. E., & Jacobs, B. L. (1979) · Science · doi:10.1126/science.451617 · Cited by 44
Increasing the Selectivity of Drug Discrimination Procedures
Appel, J. B., West, W. B., Rolandi, W. G., ALICI, T., & Pechersky, K. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00089-1 · Cited by 43
Glennon, R. A., Rosecrans, J. A., Young, R., & Gaines, J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90317-5 · Cited by 42
Winter, J. C., & Rabin, R. A. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90074-3 · Cited by 40
Effects of DOM and DMT in a proposed animal model of hallucinogenic activity
Adams, L. M., & Geyer, M. A. (1985) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(85)90074-0 · Cited by 40
Self-citationAssessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models
Sánchez, C., Arnt, J., & Moltzen, E. K. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00621-8 · Cited by 40
Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs
Glennon, R. A. (1991) · PsycEXTRA Dataset · doi:10.1037/e496182006-003 · Cited by 39
Meert, T. F., Haes, P. D., Vermote, P. C. M., & Janssen, P. A. J. (1990) · Drug Development Research · doi:10.1002/ddr.430190403 · Cited by 39
Krebs-Thomson, K., & Geyer, M. A. (1996) · PubMed · Cited by 39
Self-citationKillinger, B. A., Peet, M. M., & Baker, L. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.014 · Cited by 38
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice
Benneyworth, M. A., Smith, R. L., Barrett, R. J., & Sanders‐Bush, E. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2108-z · Cited by 38
Alterations of serotonin and LSD receptor binding following repeated administration of LSD
Trulson, M. E., & Jacobs, B. L. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90078-x · Cited by 38
Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
Trulson, M. E., Ross, C. A., & Bl, J. (1976) · PubMed · Cited by 38
The use of drug discrimination procedures to characterize hallucinogenic drug actions.
Appel, J. B., & Cunningham, K. A. (1986) · PubMed · Cited by 38
Site-Selective Serotonin Agonists as Discriminative Stimuli
Glennon, R. A. (1988) · Springer eBooks · doi:10.1007/978-3-642-73223-2_2 · Cited by 37
Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice
Yamamoto, T., & Ueki, S. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90278-2 · Cited by 36
A characterization of LSD-antagonist effects of pirenperone in the rat
Colpaert, F. C., & Janssen, P. A. J. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90216-2 · Cited by 36
Schreiber, R. D., & Vry, J. D. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38189-9 · Cited by 35
Dulawa, S. C., Hen, R., Scearce-Levie, K. A., & Geyer, M. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10176.x · Cited by 33
Self-citationGogos, A., Bogeski, M., & van den Buuse, M. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830cd822 · Cited by 33
Joordens, R. J. E., Hijzen, T. H., & Olivier, B. (1998) · Psychopharmacology · doi:10.1007/s002130050729 · Cited by 31
Heym, J. H., Rasmussen, K., & Jacobs, B. L. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90030-x · Cited by 31
Discriminative stimulus properties of the hallucinogenic agent DOM.
Young, R., Glennon, R. A., & Rosecrans, J. A. (1980) · PubMed · Cited by 31
Marona‐Lewicka, D., & Nichols, D. E. (1995) · Psychopharmacology · doi:10.1007/bf02245809 · Cited by 30
Sanders‐Bush, E., & Pj, C. (1986) · PubMed · Cited by 29
Owens, M. J., Knight, D. L., Ritchie, J., et al. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23120-2 · Cited by 27
Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats
Krebs-Thomson, K., & Geyer, M. A. (1994) · Psychopharmacology · doi:10.1007/bf02245219 · Cited by 27
Self-citationMos, J., Olivier, B., & Tulp, M. T. M. (1992) · Drug Development Research · doi:10.1002/ddr.430260311 · Cited by 27
Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide
Trulson, M. E., Ross, C. A., & Jacobs, B. L. (1977) · Neuropharmacology · doi:10.1016/0028-3908(77)90135-6 · Cited by 26
Darmani, N. A., & Reeves, S. L. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(96)00072-x · Cited by 26
Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide
Adams, L. M., & Geyer, M. A. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90022-x · Cited by 26
Self-citationMonte, A. P., Marona‐Lewicka, D., Kanthasamy, A., Sanders‐Bush, E., & Nichols, D. E. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00006a015 · Cited by 26
5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian Gerbil
Eison, A. S., & Wright, R. N. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90649-z · Cited by 25
The stimulus properties of LSD in C57BL/6 mice
Winter, J. C., Kieres, A. K., Zimmerman, M. D., Reissig, C. J., Eckler, J. R., Ullrich, T., Rice, K. C., Rabin, R. A., & Richards, J. B. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.05.014 · Cited by 25
Glennon, R. A., Titeler, M., Lyon, R. A., & Slusher, R. M. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00399a031 · Cited by 23
Hallucinogens and serotonergic mechanisms.
Glennon, R. A., Teitler, M., & Sanders‐Bush, E. (1992) · PubMed · Cited by 23
Darmani, N. A. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050085 · Cited by 22
Abramson, H. A., Rolo, A., Sklarofsky, B., & Stache, J. (1960) · The Journal of Psychology · doi:10.1080/00223980.1960.9916396 · Cited by 22
Direct comparison of hallucinogenic phenethylamines and d-amphetamine on dorsal raphe neurons
Penington, N. J., & Reiffenstein, R. J. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90420-6 · Cited by 20
Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity
Li, J., Rice, K. C., & France, C. P. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3281f19ca0 · Cited by 19
Kabeš, J., Fink, Z., & Roth, Z. (1972) · Psychopharmacology · doi:10.1007/bf00414415 · Cited by 18
Strain‐dependent serotonin neuron feedback control: role of serotonin2Creceptors
Calcagno, E., & Invernizzi, R. W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06880.x · Cited by 17
Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation
Hameleers, R., Blokland, A., Steinbusch, H. W. M., et al. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.011 · Cited by 16
Li, J., Rice, K. C., & France, C. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145458 · Cited by 16
Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives
Huang, X., Marona‐Lewicka, D., Pfaff, R. C., & Nichols, D. E. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90172-4 · Cited by 16
Serotonin and serotonin receptors in hallucinogen action
Halberstadt, A., & Nichols, D. (2020) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(10)70103-x · Cited by 15
Self-citationLSD-25 as a discriminative stimulus for response selection by pigeons
Järbe, T. U. C. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90279-8 · Cited by 15
Binding Properties of Dipropyltryptamine at the Human 5-HT1a Receptor
Thiagaraj, H. V., Russo, E. B., Burnett, A., Goldstein, E., Thompson, C. M., & Parker, K. K. (2005) · Pharmacology · doi:10.1159/000085649 · Cited by 15
Actions of methoxylated amphetamine hallucinogen on serotonergic neurons of the brain
Penington, N. J. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00076-0 · Cited by 13
Neurochemical Evidence That Hallucinogenic Drugs Are 5=HT1C Receptor Agonists: What Next?
Sanders‐Bush, E. (1994) · PsycEXTRA Dataset · doi:10.1037/e495832006-011 · Cited by 11
Lee, E. H. Y., & Geyer, M. A. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90012-x · Cited by 11
Self-citationResponse of single raphé neurons to (+)-LSD: correlation with (+)-LSD binding in brain
Bennett, J. L., & Aghajanian, G. K. (1976) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1976.tb02779.x · Cited by 9
Trulson, M. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90365-5 · Cited by 9
Antimescaline properties of some lysergic acid derivatives
Borsy, J., Huszti, Z., & Fekete, M. (1963) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(63)90002-9 · Cited by 8
Pharmacologic Challenge in ERP Researcha
Tueting, P. A., Metz, J. T., Rhoades, B. K., & Boutros, N. N. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22847.x · Cited by 5
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 475
Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
Metadata
- Authors
- Halberstadt, A. L., & Geyer, M. A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 61
- Issue
- 3
- Pages
- 364-381
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2080123927
- Cited by
- 411
- References
- 276
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.